CONy 2022 View overview page

Should findings from monogenic dementias inform sporadic disease research?

The validity of the amyloid cascade hypothesis of Alzheimer’s disease

Efforts to understand the pathological mechanisms of neurodegenerative processes

Including people with Down syndrome in Alzheimer’s disease research

The current state of gene editing in treating Alzheimer’s disease

Limitations in understanding Alzheimer’s disease for gene editing

Implications of heterogeneity in Alzheimer’s disease

Opportunities and challenges of biomarkers in Alzheimer’s disease

Unanswered questions in Alzheimer’s disease research

Selective neuronal vulnerability in neurodegenerative diseases

What are the most vulnerable neurons to AD?

Validation of scRNAseq results to understand neuron vulnerability”

Herpes simplex virus and Alzheimer’s disease

Implications of gene expression data for vulnerable neurons in AD

Therapeutic implications of caspase-cleaved tau in AD

Reducing the risk of dementia in APOE carriers with antiviral therapy